Explore › Intervention › Patient Access to Records
Intervention

Patient Access to Records

Also known as: Access to NNRTI-based antiretroviral therapy program (nevirapine + lamivudine + zidovudine or stavudine) for HIV-infected women previously exposed to single-dose nevirapine for PMTCT Patient Access to Records ART ACCESS ARV
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
HIV infection1
outcomes
All-cause mortality1
populations
Pregnant Women1
studys
PMC27824811

Findings (27)

None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →
None
improvement

Access to an NNRTI-based ART program more than halved mortality among a cohort of HIV-infected women who had previously received single-dose nevirapine for PMTCT, with the reduction remaining signific

Effect: improvement; RH = 0.46; CI: 95% CI: 0.23-0.91

Size: RH = 0.46 CI: 95% CI: 0.23-0.91
PMC2782481
Finding details → · Paper → · Graph →

Papers (1)